6-Gingerol induces cell-cycle G1-phase arrest through AKT–GSK 3β–cyclin D1 pathway in renal-cell carcinoma

Shan Xu,Haibao Zhang,Tianjie Liu,Wenjie Yang,Wei Lv,Dalin He,Peng Guo,Lei Li
DOI: https://doi.org/10.1007/s00280-019-03999-9
2020-01-01
Cancer Chemotherapy and Pharmacology
Abstract:6-Gingerol, a major biochemical and pharmacological active ingredient of ginger, has shown anti-inflammatory and antitumor activities against various cancers. Searching for natural products with fewer side effects for developing adjunctive therapeutic options is necessary.
What problem does this paper attempt to address?